BRCA1 and BRCA2 (Breast Cancer) genes are tumor suppressors and repair damaged areas of DNA to avoid pathological changes in tissues. Their mutations are responsible for a significant increase in the likelihood of developing breast cancer.

Scientific studies report that:

• Abnormal forms of BRCA1 and BRCA2 occur in approximately 10% of breast cancers.
• Mutations in the BRCA1 gene present an overall risk of developing the disease at the level of 80% until 90 years old.
• Mutations in BRCA1 have also been associated with ovarian cancer with an estimated risk of 55%.
• BRCA2 also participates in its abnormal forms in tumorigenesis, with ovarian cancer's risk as high as 25%.
• Mutations in the BRCA genes have been associated in men with breast and prostate cancer
• Mutations in the BRCA genes have also been associated with pancreatic carcinomas, leukemia and lymphomas.

The gene analysis is recommended for high-risk individuals (carriers of pathogenic mutation - mutations) and depending on the results, the individual should (or should not) undergo genetic counseling and a strict clinical surveillance program with:

• Clinical breast examination, every six months, from the age of 25, or annual mammography and/or MRI from the age of 25
• The possible choice to undergo preventive mastectomy taking into account the age of possible diagnosis of breast cancer in the examinee herself or her family medical history
• The possible choice of salpingo-oophorectomy in women who have already given birth

Simple blood collection at any time of the day (7.30-19.30) without any restrictions on food - medicines - diseases

Possibility of sending a sample For information contact 2106983222

Result in about 1 month